Inverness Graham Investments

What Inverness Graham Investments does

Inverness Graham Investments is an operationally focused private investment firm founded in 2003 by Kenneth A. Graham, building on the 60-year operating heritage of the Graham Group. The firm is headquartered in Wayne, Pennsylvania, and invests in founder-owned and founder-led businesses in the North American lower middle market, executing majority control buyouts typically of $40M-$80M equity in companies with $10M-$100M revenue and up to $20M EBITDA under its Flagship strategy, and $20M-$50M equity checks under its Green Light sustainability-focused strategy. Across more than two decades the firm has completed over 110 transactions, managing over $1.8 billion in assets under management as of May 2026, with Fund V closing at $400 million.

The firm employs a proprietary Strategic Platform Build approach, partnering with founder-management teams and contributing business-building expertise, operational resources from its Value Creation Group, and strategic add-on acquisitions to accelerate growth. Deal sourcing is supported by an Industry Executive Partner network of 40+ current and former C-suite executives who develop investment themes and source targets proactively. The firm generates revenue through management fees on committed fund capital and carried interest on portfolio exits, with its limited partner base comprising institutional investors including endowments, foundations, pension funds, and family offices. The portfolio spans 20+ active companies across healthcare (Innovia Medical, VitalPath, Biolyst Scientific), tech-enabled services and software (Syntrio, Cognito Forms, Alliant, BenefitHub, GPS Trackit, Corsica Technologies), advanced manufacturing (EiKO Global, KICTeam, Smartflow), and sustainability (Custom Agronomics, My Yield).

Name

Inverness Graham Investments

Legal name

Inverness Graham

Website

https://invernessgraham.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Inverness Graham Investments is a Wayne, Pennsylvania-based private equity firm founded in 2003 that acquires founder-owned healthcare, software, advanced manufacturing, and sustainability businesses in the North American lower middle market, managing over $1.8 billion in AUM.

Ownership category

akta.pro rank

Product category

Private Equity / Buyout Fund Management

NAICS

All Other Financial Investment Activities (52399), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282)

akta.pro primary industry

Multi-Sector / Generalist Growth Equity (FSANACAO)

akta.pro secondary industry

Corporate Strategy Advisory (BPAHADAA)

Keywords

• Private equity buyouts
• Lower middle market investing
• Growth capital
• Fund management services
• Operational value creation

Headquarters

HQ city

Newtown Square

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Fund Management Fees and Carried Interest: Inverness Graham generates revenue through management fees charged on assets under management across its Flagship and Green Light fund strategies, as well as carried interest (performance fees) generated upon successful exits of portfolio investments. The firm raised over $825 million in capital commitments over the past three years across all vehicles and strategies, culminating in Fund V closing at $400 million, bringing total AUM to more than $1.8 billion.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Inverness Graham Investments is an operationally focused private equity firm that acquires controlling stakes in founder-owned and founder-led businesses in the North American lower middle market. The firm executes two fund strategies: a Flagship strategy targeting healthcare, tech-enabled services/software, and advanced manufacturing companies with $10M–$100M revenue and up to $20M EBITDA (equity checks of $40M–$80M), and a Green Light sustainability-focused strategy targeting companies with up to $10M EBITDA (equity checks of $20M–$50M). Across both strategies, the firm provides majority control capital, operational support via its Value Creation Group and Industry Executive Partners, and drives growth through organic expansion and strategic add-on acquisitions.

Product overview

Inverness Graham Investments is an operationally focused private equity firm, not a technology product company. The firm executes two distinct investment strategies: the Flagship Strategy targeting high-growth businesses in Healthcare, Tech-Enabled Services/Software, and Advanced Manufacturing; and the Green Light Strategy targeting sustainability-focused tech-enabled businesses. The firm employs a Strategic Platform Build approach to build enduring value through operational enhancements and transformative M&A. The firm's portfolio of 20+ active investments spans diverse sectors including professional education technology (Axcel Learning), healthcare manufacturing (Innovia Medical, VitalPath, Biolyst Scientific), enterprise software (Syntrio, Cognito Forms, Spirion), marketing technology (Alliant), fleet management (GPS Trackit), agriculture technology (My Yield, Custom Agronomics), and various industrial and service businesses. The firm manages over $1.8 billion in assets under management across its diversified lower middle market platform.

Differentiator

Problem solved

Functional benefit

Brands

• Strategic Platform Build: The firm's proprietary approach to building businesses of enduring value through operational enhancements and transformative M&A.
• Value Creation Group
• Industry Executive Partner Program

Products and services

• Inverness Graham Flagship Strategy Private equity investment strategy targeting high-growth businesses in Healthcare, Tech-Enabled Services/Software, and Advanced Manufacturing with majority control investments of $40M–$80M equity in companies with $10M–$100M revenue and up to $20M EBITDA.
• Inverness Graham Green Light Strategy Sustainability-focused private equity investment strategy targeting tech-enabled businesses where environmental sustainability drives growth acceleration, with equity investments of $20M–$50M in companies with up to $10M EBITDA across AgTech, energy transition, industrial transition, and built world transition themes.
• Strategic Platform Build Approach Proprietary value creation approach refined over two decades, supporting portfolio management teams to drive organic growth while scaling platforms strategically through add-on acquisitions, paired with operational resources from the Value Creation Group and Industry Executive Partners.
• Inverness Graham Investments V (Fund V) Fifth flagship buyout fund of Inverness Graham, closed at $400 million, with proceeds used to continue the strategy of partnering with founder-owned and founder-led businesses in Healthcare, Tech-Enabled Services and Software, and Advanced Manufacturing sectors.

Quantifiable outcome

• 110+ transactions completed across 21 years of operating history
• +3 more outcomes

Named customers16 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Partnerships

Four partnerships are on record, tiered core and add-on.

• Latham & Watkins LLPcoreImplementation/ SI/ Consulting Partner · 13 May 2026Latham & Watkins LLP served as legal counsel for the Fund V closing. The firm provides legal advisory services for fund formation, regulatory compliance, and transaction documentation across Inverness Graham's investment activities.
• Grace Medicaladd-onStrategic or Co-development Partner · 8 July 2025Innovia Medical (an Inverness Graham portfolio company) acquired Grace Medical, a Memphis-based maker of single-use surgical implants and instruments for ENT (Ear, Nose, and Throat) procedures. The acquisition expanded Innovia's presence in the ENT surgical market and enhanced its product portfolio and manufacturing capabilities.
• Hurricane Medicaladd-onStrategic or Co-development Partner · 8 July 2025Innovia Medical (an Inverness Graham portfolio company) acquired Hurricane Medical, a Bradenton, Florida-based manufacturer of single-use ophthalmic surgical products. The acquisition expanded Innovia's presence in the ophthalmic surgical market and created synergy opportunities with new and existing customers.
• AnalyticsIQadd-onStrategic or Co-development Partner · 30 June 2025Alliant (an Inverness Graham portfolio company) acquired AnalyticsIQ, a predictive analytics and people-based marketing data company. The acquisition combined Alliant's proprietary transaction data with AnalyticsIQ's predictive modeling capabilities to create a differentiated data platform. Scarlett Shipp, formerly CEO of AnalyticsIQ, was appointed CEO of the combined business.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Graham Partners: Family-affiliated operationally focused private equity firm investing in advanced manufacturing, industrial technology, and consumer-related businesses, with a similar middle-market buyout approach and Graham family heritage.
• Audax Group: One of the largest lower middle market PE platforms with a similar buy-and-build approach targeting founder-owned businesses with $10M-$100M revenue, making it a direct competitor in deal sourcing and platform construction.
• Shore Capital Partners: Lower middle market PE firm focused on healthcare, food and beverage, and business services, with a comparable thesis around founder-led businesses and Strategic Platform Build-style execution (and the original sponsor of Innovia Medical before Inverness Graham's acquisition).
• Genstar Capital: Lower middle market PE firm investing in technology, healthcare, financial services, and industrials, with a similar buyout orientation and multi-vertical platform approach.
• Frontenac Company: Lower middle market PE firm focused on founder-owned businesses with $10M-$100M revenue, closely comparable in target company profile and value creation orientation to Inverness Graham.
• Trinity Hunt Partners: Lower middle market growth-oriented PE firm investing in business services, healthcare, and consumer companies, with comparable deal size and operating partner engagement model.
• Brentwood Associates: Lower middle market PE firm focused on consumer, healthcare, and business services, with comparable founder-friendly positioning and platform-build approach.

Broad incumbents

• L Catterton: Large consumer-focused PE firm with diversified strategies including a growth fund that competes for platform deals in the lower middle market, overlapping with Inverness Graham's consumer/retail portfolio companies like Treat Planet.
• Avista Capital Partners: Healthcare-focused PE firm that competes with Inverness Graham in healthcare platforms, medical device manufacturing, and pharma services investments across the middle market.
• Linden Capital Partners: Healthcare-specialist PE firm operating in the lower middle market, directly comparable in healthcare verticals like medical devices and lab consumables.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/inverness-graham-investments

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A15 records

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inverness Graham Investments